RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease

Front Biosci (Schol Ed). 2012 Jan 1;4(1):240-50. doi: 10.2741/s265.

Abstract

RAGE, a receptor for advanced glycation endproducts, is an immunoglobulin-like cell surface receptor that is often described as a pattern recognition receptor due to the structural heterogeneity of its ligand. RAGE is an important cellular cofactor for amyloid beta-peptide (Abeta)-mediated cellular perturbation relevant to the pathogenesis of Alzheimer's disease (AD). The interaction of RAGE with Abeta in neurons, microglia, and vascular cells accelerates and amplifies deleterious effects on neuronal and synaptic function. RAGE-dependent signaling contributes to Abeta-mediated amyloid pathology and cognitive dysfunction observed in the AD mouse model. Blockade of RAGE significantly attenuates neuronal and synaptic injury. In this review, we summarize the role of RAGE in the pathogenesis of AD, specifically in Abeta-induced cellular perturbation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology*
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Humans
  • Microglia / metabolism
  • Microglia / pathology
  • Molecular Targeted Therapy
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic / metabolism*

Substances

  • Amyloid beta-Peptides
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic